Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07541898Not ApplicableNot Yet Recruiting

Effects of Berberine on Cardiometabolic Outcomes

Role: collaborator

NCT07500649Not ApplicableRecruiting

Project SIRT6 Activator

Role: collaborator

NCT07451496Not ApplicableRecruiting

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

Role: collaborator

NCT06230861Not ApplicableRecruiting

Effects of Quercetin on Cardiometabolic Outcomes

Role: collaborator

NCT06186102Phase 2Active Not Recruiting

Polyamine Treatment in Elderly Patients With Coronary Artery Disease

Role: collaborator

NCT06889142Not ApplicableNot Yet Recruiting

Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure

Role: collaborator

All 6 trials loaded